Trabelsi, Khaled
Zakour, Meriem Ben
Jordan, Ingo
Sandig, Volker
Rourou, Samia
Kallel, Hela
Funding for this research was provided by:
bilateral scientific cooperation between Tunisia and Germany (STC-TUNGER-044, STC-TUNGER-044, STC-TUNGER-044, STC-TUNGER-044, STC-TUNGER-044, STC-TUNGER-044)
Article History
Received: 15 March 2022
Accepted: 7 June 2022
First Online: 17 June 2022
Declarations
:
: The CR.pIX cell line was generated by ProBioGen and published previously. The potency assays were conducted at the animal facility of Institut Pasteur de Tunis; animal experimentation was conducted according to national and international guidelines such as those issued by OLAW (Office of Laboratory Animal Welfare). The Ethics Committee of the Institut Pasteur de Tunis approved the protocol. Experimental research complied with institutional biosafety and biocontainment guidelines.
: Not applicable.
: IJ and VS are listed as inventors on patents that protect the anatine cell line (WO 2005/042728 A3).